Risk factor
Very poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
CG Invites Co., Ltd., based in Seoul, South Korea, specializes in the groundbreaking discovery and progression of novel medical treatments. Founded on July 7, 2000, by Cho Joong Myung and Ro Seong Gu, the company's operations are divided into two main areas. Its Pharmaceutical Research and Development segment primarily focuses on utilizing digital genomics for drug innovation. Additionally, the Automation Equipment division is responsible for manufacturing machinery, including hot pack and printed circuit board (PCB) equipment.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E.